Sanctura FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 28, 2004)
Brand name: Sanctura
Generic name: trospium chloride
Dosage form: Tablets
Company: Allergan plc
Treatment for: Urinary Frequency, Urinary Incontinence, Overactive Bladder
Marketing Status: Discontinued
Sanctura (trospium chloride) is an antispasmodic, antimuscarinic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Development timeline for Sanctura
Date | Article |
---|---|
Aug 6, 2007 | Approval Indevus Announces FDA Approval of Sanctura XR |
May 28, 2004 | Approval Sanctura Indevus Pharmaceuticals, Inc. - Treatment for Overactive Bladder |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.